AANS Neurosurgeon | Volume 26, Number 1, 2017

Advertisement

Researchers Shed Light on Pathway from Virus to Brain Disease

Bookmark and Share

Up to 80 percent of healthy adults can become infected with progressive multifocal leukoencephalopathy (PML) caused by the John Cunningham polyomavirus (JCV). Normally, JCV is completely harmless. For those who are suffering from an issue that can cause a suppressed immune system, such as AIDS, JCV can develop into brain disease in which the brain’s white matter becomes affected. Patients who are also taking immunosuppressant drugs for autoimmune conditions also have a higher chance of developing the disease. Currently, this disease is most common in patients with MS who have the virus and are taking immunosuppressant therapy called natalizumab. “Nobody comes away unscathed from PML – you either die or you’re left with a lifelong searing neurological defect,” said Aron E. Lukacher, chair and professor of microbiology and immunology. “Because we don’t know how the drugs cause the JC virus to amplify from a silent infection, we really have no way of controlling it.” To read more, click here.

Calendar/Courses

Microsurgery Course Zurich
March 29-April 1, 2017; Zurich, Switzerland

12th World Congress on Brain Injury
March 29-April 1, 2017; New Orleans

2017 National Neuroscience Review
March 31-April 1, 2017; National Harbor, Md.

Brain & Brain PET 2017
April 1-4, 2017; Berlin, Germany

Neurosurgical Society of America Annual Meeting 2017
April 2-5, 2017; Jacksonville, Fla.

Interactive Calendar

Comments are closed.